Drug
Alpha-glycerophosphoric acid clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2020
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Baxter Healthcare Corporation (2) · Ain Shams University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses alpha-glycerophosphoric acid is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%ECompletedPhase 1Baxter Healthcare CorporationNCT06842134Written as Sodium Glycerophosphate Injection
- A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Inorganic Phosphate (Sodium Phosphates Injection, USP)CompletedPhase 1Baxter Healthcare CorporationNCT06842121Written as Sodium Glycerophosphate Injection
- Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICUStatus unknownPhase 4Ain Shams UniversityNCT04519762Written as Glycophos (Sodium Glycerophosphate)
As the comparator · 1 — what is tested is compared with alpha-glycerophosphoric acid
Codes
What other systems call alpha-glycerophosphoric acid · ClinicalTrials.gg INT002897
- MeSH (NLM) C029620alpha-glycerophosphoric acidConfirmed ClinicalTrials.gov, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C029620 | alpha-glycerophosphoric acid | Confirmed ClinicalTrials.gov, NLM |
Also registered as sodium glycerophosphate (UNII RCS9EQ01V4 · RxNorm 1595589).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.